Menu Close

Chronic Health Conditions Related to Dental Health and Dental Procedures

Medical studies and clinical results have found that many chronic, degenerative, health conditions are dental-related (there are also other causes and effects are cumulative and synergistic). The main causes include mercury (from amalgam flings) and infections from root-canaled teeth (most are infected) and Tom cavitations (chronically infected tooth extractions sites or root-canal sites), as well as gingivitis and periodontitis (infected gums). Oral infections have been found to be factors in cardiovascular disease, heart conditions, stroke, arthritis, etc. Extremely high levels of mercury have been found to accumulate in gums, oral mucosa, and saliva of those with amalgam fillings or metal crowns over amalgam- causing chronic oral conditions and distribution of mercury to all organs of the body through the blood. Mercury, root-canaled teeth, and cavitations are common causes of chronic conditions (documentation below), and most with many chronic conditions like CFS, Fibromyalgia, MS, depression, oral conditions, etc. recover when they deal with whichever of these is affecting them. The majority(over 50%) of wisdom tooth extraction sits have cavitations- which can be extremely toxic systemically and cause disabling conditions like cancer, CFS, MS, ALS, Parkinson ’s, Rheumatoid Arthritis, cardiovascular disease, etc.

The majority of root-canaled teeth likewise accumulate bacteria and become toxic over time, causing the same kinds of conditions. Dental amalgam is the largest source of mercury in most people with mercury amalgam fillings. Most with several amalgam dental fillings or metal crowns over amalgam get mercury exposure above the government health guidelines and are affected over time, which commonly causes or is a major factor in such conditions. Some are more susceptible than others and are more seriously affected or sooner affected, but all who have them are affected to some measurable degree by these over time. Tests are now available for measuring exposure and effects such as immune reactivity, metabolic elects, enzymatic blockages, improperly functioning detox pathways, mineral imbalances, etc. that are factors in these conditions. In surgical clinical trials of FDA and medical school, approximately 80% of wisdom tooth extraction sites were found to have cavitations (the population tested may not be exactly the same as the general population but was a large population). Likewise, FDA clinical dials by the Cavitat found similar numbers, with follow-up surgical treatment. Most such sites have cavitations- which can cause serious health elects not commonly diagnosed as to the real cause. The sites are locally relatively pain-free in many cases, but there are major systemic effects from bacterial toxins and infection. They can also cause major pain (NICO)

Bioassay test at the dental labs of Dr. Haley and Dr. Bouquet find similar high toxicity and effect in root Canaled teeth, which also are commonly found to have cavitations by the methods above. Years of research by Dr. Westin Price (dental association researcher) and prominent doctors documented the same thing. Thousands of people who have had cavitation surgery or proper extraction of root-canaled teeth have recovered from disabling chronic conditions such as the above.

DAMS, a national patents support organization with coordinators in most states, works with thousands of disabled and chronically ill people each year and have compiled many thousands of cases of recovery Iron over 40 major chronic conditions after proper diagnosis and treatment for mercury toxicity root canal toxicity, or cavitation toxicity Over 50,000 clinical cases of recovery are documented in the first web site paper, and we and the other sources have many hundreds of cases of documented recoveries from disabling conditions also dealing with root-canaled teeth and cavitations. Any of the several oral surgeons we interact with dealing with cavitations or root-canaled teeth have had large numbers of cases of recovery from chronic or disabling condit0hS fr0M Chronic OF disabling conditions after treatment Bob Jones, who invented the cavitate recovered from ALS after cavitation surgery, and we know of many other cases of recovery from such conditions in people DAMS has worked with.


The inflammatory component of both cancer and other systemic entities is within our control. Understanding the importance of early recognition and instituting measures for control is precisely what periodontal management is all about. Our ability to suppress the inflammatory response with instrumentation, adjunctive therapy (including host modulation), and daily disease control, puts the general practitioner and hygienist at the forefront of this enormous public health issue, and we can make a huge difference.


  1. Glick M. Exploring our role as health care providers: the oral-medical connection. J Am Dent Assoc. 2005;136:716-720.
  2. Paster BJ, Olsen I, Aas JA, et al. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006;42:80-87.
  3. Kroes I, Lepp PW, Relman DA. Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci U S A. 1999;96:14547-14552.
  4. Feng Z, Weinberg A. Role of bacteria in health and disease of periodontal tissues. Periodontol 2000. 2006;40:50-76.
  5. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000. 2005;38: 135-187.
  6. Tonetti MS, Gerber L, Lang NP. Vascular adhesion molecules and initial development of inflammation in clinically healthy human keratinized mucosa around teeth and osseointegrated implants. J Periodontal Res. 1994;29:386-392.
  7. Gemmell E, Marshall RI, et at. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000. 1997; 14:112-143.
  8. Teles RP, Haffajee AD, Socransky SS. Microbio-logical goals of periodontal therapy. Periodontol 2000. 2006;42:180-218.
  9. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol. 2005;7:3-7.
  10. Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000. 2006;40:77-93.
  11. van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004; 59:713-721.
  12. Bostrom L, Linder LE, Bergstrom J. Smoking and cervicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol. 1999;26:352-357.
  13. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab invest. 1976;34:235-249.
  14. Teng YT. The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med. 2003;14:237-252.
  15. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76(11 suppl): 2106-2115.
  16. Beck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005;112:19-24.
  17. Offenbacher S, Boggess KA, Murtha AP, et al. Progressive periodontal disease and risk of very preterm delivery [published correction appears in Obstet Gynecol. May 2006;107:1171]. Obstet Gynecol. Jan 2006;107:29-36.
  18. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28:27-32.
  19. Williams RC, Offenbacher S. Periodontal medicine: the emergence of a new branch of periodontology. Periodontol 2000. 2000;23: 9-12.
  20. Grau AJ, Becher H, Ziegler CM, et al. Periodontal disease as a risk factor for ischemic stroke. Stroke. 2004;35:496-501.
  21. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71:1554-1560.
  22. Starkhammar Johansson C, Richter A, Lund-strom A, et al. Periodontal conditions in patients with coronary heart disease: a case control study. J Clin Periodontol. 2008;35:199-205.
  23. Turkoglu O, Baris N, Kutukculer N, et al. Evaluation of serum anti-cardiolipin and oxidized low- density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol. 2008;79:332-340.
  24. Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol. 1996;23(3 pt 1):194- 202.
  25. Loe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329-334.
  26. Scannapieco FA. Periodontal inflammation: from gingivitis to systemic disease? Compend Contin Educ Dent. 2004;25(7 suppl 1):16-25.
  27. Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease: a systematic review. Ann Periodontol. 2003;8:54-69.
  28. Krall EA. The periodontal-systemic connection: implications for treatment of patients with osteoporosis and periodontal disease. Ann Periodontol. 2001;6:209-213.
  29. Kunnen A, Blaauw J, van Doormaal JJ, et al. Women with a recent history of early-onset pre- eclampsia have a worse periodontal condition. J Clin Periodontol. 2007;34:202-207.
  30. Stein PS, Desrosiers M, Donegan SJ, et al. Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc. 2007;138:1314-1322.
  31. Ebersole JL, Machen RL, Steffen MJ, et al. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol. 1997; 107:347-352.
  32. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619.
  33. Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000. 2001;25:21-36.
  34. Tezal M, Sullivan MA, Reid ME, et al. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 2007;133:450-454.
  35. Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst. 2007;99:171-175.
  36. Glick M. Risky liaisons: what is the relationship between oral conditions and nonoral diseases? J Am Dent Assoc. 2007;138:1056-1060.